시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 감염증 체외진단 시장 보고서(2025년)
Infectious Disease In Vitro Diagnostics Global Market Report 2025
상품코드 : 1889487
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,586,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,520,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,454,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

감염증 체외진단 시장 규모는 최근 수년간 현저한 성장을 이루고 있습니다. 2024년 141억 4,000만 달러에서 2025년에는 151억 달러로, CAGR 6.7%로 확대되었습니다. 지난 수년간의 성장 요인으로는 항생제 내성 증가, 세계화와 여행 증가, 고령화, 새로운 병원체 출현, 바이오테러리즘 위협 등이 있습니다.

감염증 체외진단 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 198억 3,000만 달러에 달하고, CAGR은 7.0%를 나타낼 전망입니다. 예측기간의 성장은 포인트오브케어 검사(POCT)에 대한 수요 증가, 감염증의 유병률 상승, 맞춤 의료의 보급 확대, 신흥 시장에서의 의료 인프라의 확충 등이 요인으로 예상됩니다. 예측 기간의 주요 동향은 차세대 시퀀싱, 마이크로플루이딕스 기반 플랫폼, 랩온어칩 기술, 다중 중합효소 연쇄반응(PCR) 분석, 디지털 면역 측정법 등이 있습니다.

과거의 세계적인 감염증 증가가 감염증 체외진단 시장의 성장을 이끌어 냈습니다. 감염증이란 특정 시기에 세계 인구에 영향을 미치는 세균성, 바이러스성, 진균성 또는 기생충성 감염을 의미하며 전반적인 질병 부담을 반영합니다. 기후 변화에 의해 모기 등의 매개생물의 서식지가 확대되면서 감염증의 확산이 세계적으로 증가하고 있습니다. 감염증 체외진단은 의료 종사자가 병원체를 검출하고 적절한 치료 및 통제가 가능하도록 정확하고 신속한 진단 도구를 제공함으로써 이러한 동향을 지원합니다. 예를 들어, 2024년 10월에 세계보건기구(WHO)가 보고한 바에 의하면, 세계적으로 약 1,080만명이 결핵에 감염되었으며, 남성 55%, 여성 33%, 소아 및 청소년 12%, HIV 감염자 6.1%였습니다. 따라서 세계적인 감염증 확산은 과거 기간 동안 감염증 체외진단 시장의 발전에 기여했습니다.

감염증 체외진단 시장의 주요 기업은 신속한 진단 실현, 환자 예후 개선, 포인트오브케어 검사 확대를 목적으로 여러 소화기 병원체를 신속하게 검출하는 제품 등의 혁신적인 제품을 개발하고 있습니다. 다수의 소화기 병원체의 신속한 검출은 단일 시료로부터 소화관 내의 다수의 병원 미생물을 신속하게 확인하는 진단 검사를 포함합니다. 2024년 6월 미국에 본사를 둔 제품, 화학제품, 진단제 공급기업 MP Biomedicals는 소화기 감염증용 면역 크로마토그래피 신속 진단 키트를 출시했습니다. 이 키트는 헬리코박터 파일로리, 살모넬라 티피, 콜레라균 혈청형 O1과 O139의 신속하고 정확한 검출을 가능하게 합니다. 본 키트는 신속한 현장 진단(포인트 오브 케어)에 의한 정성 검출을 뒷받침하며 대변, 혈액, 혈장, 혈청, 물, 식품 등 다양한 검체에 대응 가능합니다. 임상 현장과 연구 모두에 적합하며, 면역 크로마토그래피 기술을 활용하여 조기 진단, 치료 경과 모니터링, 병원체 살균 확인을 지원합니다. 또한 신속성, 정밀도, 폭넓은 병원체 검출 범위를 겸비한 솔루션을 제공하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

제36장 부록

CSM
영문 목차

영문목차

Infectious disease in vitro diagnostics are laboratory tests performed on samples such as blood, urine, or swabs to detect, identify, and monitor infectious pathogens including bacteria, viruses, fungi, and parasites. These diagnostics enable accurate and timely diagnosis, guide treatment decisions, and support disease surveillance and infection control.

The main product types in infectious disease in vitro diagnostics are instruments, reagents, and software and services. Instruments are tools or devices used to measure and monitor environmental conditions including air, water, soil, and noise. They utilize technologies such as molecular diagnostics, immunoassay, microbiology, hematology, urinalysis, and others. Applications include methicillin-resistant Staphylococcus aureus, Clostridium difficile, respiratory viruses, tuberculosis and drug-resistant tuberculosis, gonorrhea, human papillomavirus, human immunodeficiency virus, hepatitis C, hepatitis B, and more. End-users include hospitals, clinics, diagnostic laboratories, academic research institutes, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The infectious disease in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides infectious disease in vitro diagnostics market statistics, including infectious disease in vitro diagnostics industry global market size, regional shares, competitors with an infectious disease in vitro diagnostics market share, detailed infectious disease in vitro diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease in vitro diagnostics industry. This infectious disease in vitro diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infectious disease in vitro diagnostics market size has grown strongly in recent years. It will grow from $14.14 billion in 2024 to $15.1 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period is attributed to antibiotic resistance, globalization and travel, an aging population, the emergence of novel pathogens, and bioterrorism threats.

The infectious disease in vitro diagnostics market size is expected to see strong growth in the next few years. It will grow to $19.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, rising prevalence of infectious diseases, growing adoption of personalized medicine, and expansion of healthcare infrastructure in emerging markets. Key trends in the forecast period include next-generation sequencing, microfluidics-based platforms, lab-on-a-chip technology, multiplex polymerase chain reaction (PCR) assays, and digital immunoassays.

The rise in global infectious diseases drove the growth of the infectious disease in vitro diagnostics market during the historic period. Infectious diseases encompass bacterial, viral, fungal, or parasitic infections affecting populations worldwide at a given time, reflecting the overall disease burden. Changes in climate have expanded the habitats of vectors such as mosquitoes, increasing the global prevalence of infectious diseases. Infectious disease in vitro diagnostics support this trend by offering precise and timely diagnostic tools that allow healthcare providers to detect pathogens, initiate appropriate treatment, and control outbreaks efficiently. For example, in October 2024, the World Health Organization reported that approximately 10.8 million people worldwide contracted tuberculosis, with 55 percent men, 33 percent women, 12 percent children and adolescents, and 6.1 percent of cases among individuals living with HIV. Therefore, the rising global prevalence of infectious diseases contributed to the growth of the infectious disease in vitro diagnostics market during the historic period.

Major companies in the infectious disease in vitro diagnostics market are developing innovative products such as rapid detection of multiple gastrointestinal pathogens to enable timely diagnosis, improve patient outcomes, and expand point-of-care testing. Rapid detection of multiple gastrointestinal pathogens involves diagnostic tests that quickly identify several disease-causing microorganisms in the gastrointestinal tract from a single sample. In June 2024, MP Biomedicals, a US-based provider of products, chemicals, and diagnostics, launched immunochromatographic rapid diagnostic kits for gastrointestinal infectious diseases. These kits allow fast and accurate detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. They support rapid, point-of-care qualitative detection, versatile sample use including stool, blood, plasma, serum, water, and food, and are suitable for both clinical and research settings. Using immunochromatographic technology, they support early diagnosis, treatment monitoring, and confirmation of pathogen eradication, offering a combination of speed, precision, and broad pathogen coverage.

In January 2025, Fremman Capital, a UK-based private equity firm focused on healthcare and life sciences investments, acquired a majority stake in DIESSE Diagnostica Senese for an undisclosed sum. Fremman Capital intends to accelerate DIESSE's international growth and reinforce its position in the specialty in vitro diagnostics market by supporting innovation, expanding the product range for autoimmune and infectious disease diagnostics, and increasing production capacity at DIESSE's biotech campus, driving long-term sustainable growth. DIESSE Diagnostica Senese is an Italy-based developer of innovative in vitro diagnostics and reagents for autoimmunity, infectious diseases, and hematological testing, serving clinical laboratories worldwide.

Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, BioMerieux SA, Qiagen N.V., Becton, Dickinson and Company, Hologic, Inc., Labcorp Holdings Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Quest Diagnostics, Revvity Inc. (Formerly PerkinElmer, Inc.), OraSure Technologies, Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries, Bio-Rad Laboratories Inc., Trivitron Healthcare, and InBios International Inc.

North America was the largest region in the infectious disease in vitro diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease in vitro diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease in vitro diagnostics market consists of revenues earned by entities by providing services such as serology testing, rapid diagnostic testing, disease surveillance and monitoring, sample collection and processing, and consulting and training services. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease in vitro diagnostics market also includes sales of rapid test kits, culture media, controls and calibrators, molecular sequencing kits, flow cytometry reagents, and point-of-care diagnostic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease In Vitro Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease in vitro diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for infectious disease in vitro diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease in vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Infectious Disease In Vitro Diagnostics Market Characteristics

3. Infectious Disease In Vitro Diagnostics Market Trends And Strategies

4. Infectious Disease In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Infectious Disease In Vitro Diagnostics Growth Analysis And Strategic Analysis Framework

6. Infectious Disease In Vitro Diagnostics Market Segmentation

7. Infectious Disease In Vitro Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Infectious Disease In Vitro Diagnostics Market

9. China Infectious Disease In Vitro Diagnostics Market

10. India Infectious Disease In Vitro Diagnostics Market

11. Japan Infectious Disease In Vitro Diagnostics Market

12. Australia Infectious Disease In Vitro Diagnostics Market

13. Indonesia Infectious Disease In Vitro Diagnostics Market

14. South Korea Infectious Disease In Vitro Diagnostics Market

15. Western Europe Infectious Disease In Vitro Diagnostics Market

16. UK Infectious Disease In Vitro Diagnostics Market

17. Germany Infectious Disease In Vitro Diagnostics Market

18. France Infectious Disease In Vitro Diagnostics Market

19. Italy Infectious Disease In Vitro Diagnostics Market

20. Spain Infectious Disease In Vitro Diagnostics Market

21. Eastern Europe Infectious Disease In Vitro Diagnostics Market

22. Russia Infectious Disease In Vitro Diagnostics Market

23. North America Infectious Disease In Vitro Diagnostics Market

24. USA Infectious Disease In Vitro Diagnostics Market

25. Canada Infectious Disease In Vitro Diagnostics Market

26. South America Infectious Disease In Vitro Diagnostics Market

27. Brazil Infectious Disease In Vitro Diagnostics Market

28. Middle East Infectious Disease In Vitro Diagnostics Market

29. Africa Infectious Disease In Vitro Diagnostics Market

30. Infectious Disease In Vitro Diagnostics Market Competitive Landscape And Company Profiles

31. Infectious Disease In Vitro Diagnostics Market Other Major And Innovative Companies

32. Global Infectious Disease In Vitro Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease In Vitro Diagnostics Market

34. Recent Developments In The Infectious Disease In Vitro Diagnostics Market

35. Infectious Disease In Vitro Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기